Skip to content
Unrated Drug recall · FDA · Published September 5, 2025

Endo Everolimus Tablets 5mg Recall: Impurity Risk

Endo recalls Everolimus 5mg tablets due to impurity IP-C failing specifications. Rx-only product with specific lot number. Contact for return instructions.

🇺🇸 FDA recall #D-0026-2026DrugEndo ›
Take action

Contact the company

Recalling firmEndo USA, Inc.9 Great Valley Pkwy · Malvern, PA 19355-1304
✎ GovInfoNow plain-language explainer

Endo is recalling Everolimus 5mg tablets because they contain an impurity that doesn't meet safety standards. This is a prescription-only medication that could pose risks if taken. Read more at govinfonow.com/recall/31802-endo-everolimus-tablets-5mg-recall-impurity-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/31802-endo-everolimus-tablets-5mg-recall-impurity-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0026-2026

Cite this page

“Endo Everolimus Tablets 5mg Recall: Impurity Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31802-endo-everolimus-tablets-5mg-recall-impurity-risk. Based on FDA recall #D-0026-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0026-2026%22&limit=1).

The FDA announced on Sept. 5, 2025, that Endo USA, Inc. is recalling Everolimus tablets 5mg due to failed impurity specifications. The voluntary Class III recall affects 1,041 cartons distributed nationwide.

How to tell if you have it

  • Brand: Endo
  • Product: Everolimus tablets 5mg, 28 tablets
  • NDC: 49884-125-91
  • Lot #: 550172301
  • Exp. Date: January 2026

The hazard

The recall is due to the product being out of specification for impurity IP-C, constituting failed impurities or degradation specifications.

Context

GovInfoNow's records show Endo USA, Inc. has issued four other recalls since Nov. 18, 2024, including a March 13, 2026, recall for Buprenorphine Injection due to crystallization risk and an Oct. 10, 2025, recall for Everolimus Tablets 10mg over impurity IP-C specifications. Other recent recalls of similar products include Alembic Fesoterodine Tablets Recall (Dec. 16, 2025), Somerset Therapeutics Dexamethasone Injection Recall (Feb. 4, 2026), and Zydus Mirabegron 25mg Tablets Recall (Aug. 5, 2026).

How to tell if you have this one

Check for Everolimus 5mg tablets in cartons with 28 tablets (4 blister strips of 7 tablets each). Look for lot number 550172301 and expiration date January 2026.

  • Brand
    Endo
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Identify the lot number and expiration date on the packaging to confirm if your tablets are affected.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 47 days after the firm started it.

1. Firm started the recall: Sep 5, 202512. FDA classified it Class III: Oct 16, 202523. Published in FDA’s Enforcement Report: Oct 22, 202532025
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Endo recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0026-2026 (September 5, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0026-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA